GlassScriptPhysician profile
Timothy C Albion
NPI 1740279827
$1,214.00
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $166 · 2021: $447 · 2023: $145 · 2024: $15.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $278.49 | 2019-2021 | |
| Pfizer INC. | $112.51 | 2019-2020 | |
| Exeltis, USA INC. | $77.83 | 2019-2021 | |
| Amgen INC. | $76.69 | 2021-2023 | Prolia, Evenity |
| Evofem Biosciences, INC. | $72.85 | 2021 | |
| Hologic Sales and Service, LLC | $68.35 | 2019-2023 | Coolseal Generator, Myosure Tissue Removal Device |
| Allergan, INC. | $49.94 | 2019 | |
| Therapeuticsmd, INC. | $47.71 | 2020-2021 | |
| Agile Therapeutics, INC. | $44.77 | 2021-2023 | Twirla |
| Daiichi Sankyo INC. | $40.04 | 2019-2021 | |
| Becton, Dickinson and Company | $39.81 | 2023 | Bd Max System, Bd Max Instrument |
| Merck Sharp & Dohme LLC | $36.00 | 2019-2020 | |
| Lupin INC. | $29.79 | 2019-2021 | |
| Avion Pharmaceuticals | $28.92 | 2021 | |
| Myovant Sciences INC. | $28.46 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $21.47 | 2019 | |
| Abbott Laboratories | $20.14 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $19.28 | 2021 | |
| Shield Therapeutics INC | $17.50 | 2023 | Accrufer |
| Vertical Pharmaceuticals, LLC | $16.20 | 2019 | |
| Coopersurgical, INC. | $16.00 | 2021 | |
| Boston Scientific Corporation | $15.79 | 2024 | Advantage System |
| Amag Pharmaceuticals, INC. | $14.66 | 2019 | |
| Amneal Pharmaceuticals LLC | $13.93 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $13.87 | 2020 | |
| Dysis Medical, INC. | $13.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Albion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.